180 related articles for article (PubMed ID: 8074747)
1. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine.
Martin-Iverson MT; Todd KG; Altar CA
J Neurosci; 1994 Mar; 14(3 Pt 1):1262-70. PubMed ID: 8074747
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
[TBL] [Abstract][Full Text] [Related]
3. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra.
Altar CA; Boylan CB; Fritsche M; Jackson C; Hyman C; Lindsay RM
Exp Neurol; 1994 Nov; 130(1):31-40. PubMed ID: 7821394
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.
Altar CA; Boylan CB; Jackson C; Hershenson S; Miller J; Wiegand SJ; Lindsay RM; Hyman C
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11347-51. PubMed ID: 1454818
[TBL] [Abstract][Full Text] [Related]
5. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo.
Arenas E; Akerud P; Wong V; Boylan C; Persson H; Lindsay RM; Altar CA
Eur J Neurosci; 1996 Aug; 8(8):1707-17. PubMed ID: 8921261
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous behaviours of rats are differentially affected by substantia nigra infusions of brain-derived neurotrophic factor and neurotrophin-3.
Martin-Iverson MT; Altar CA
Eur J Neurosci; 1996 Aug; 8(8):1696-706. PubMed ID: 8921260
[TBL] [Abstract][Full Text] [Related]
7. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts.
Sauer H; Fischer W; Nikkhah G; Wiegand SJ; Brundin P; Lindsay RM; Björklund A
Brain Res; 1993 Oct; 626(1-2):37-44. PubMed ID: 8281451
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo.
Shen RY; Altar CA; Chiodo LA
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8920-4. PubMed ID: 8090745
[TBL] [Abstract][Full Text] [Related]
10. A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats.
Shults CW; Matthews RT; Altar CA; Hill LR; Langlais PJ
Exp Neurol; 1994 Feb; 125(2):183-94. PubMed ID: 8313937
[TBL] [Abstract][Full Text] [Related]
11. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain.
Mamounas LA; Blue ME; Siuciak JA; Altar CA
J Neurosci; 1995 Dec; 15(12):7929-39. PubMed ID: 8613731
[TBL] [Abstract][Full Text] [Related]
13. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder.
Valvassori SS; Mariot E; Varela RB; Bavaresco DV; Dal-Pont GC; Ferreira CL; Andersen ML; Tye SJ; Quevedo J
J Affect Disord; 2019 Feb; 245():1106-1113. PubMed ID: 30699853
[TBL] [Abstract][Full Text] [Related]
14. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon.
Hyman C; Juhasz M; Jackson C; Wright P; Ip NY; Lindsay RM
J Neurosci; 1994 Jan; 14(1):335-47. PubMed ID: 8283241
[TBL] [Abstract][Full Text] [Related]
15. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
16. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.
Mufson EJ; Kroin JS; Sobreviela T; Burke MA; Kordower JH; Penn RD; Miller JA
Exp Neurol; 1994 Sep; 129(1):15-26. PubMed ID: 7523178
[TBL] [Abstract][Full Text] [Related]
17. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons.
Yurek DM; Lu W; Hipkens S; Wiegand SJ
Exp Neurol; 1996 Jan; 137(1):105-18. PubMed ID: 8566202
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
[TBL] [Abstract][Full Text] [Related]
19. Continuous low-dose treatment with brain-derived neurotrophic factor or neurotrophin-3 protects striatal medium spiny neurons from mild neonatal hypoxia/ischemia: a stereological study.
Galvin KA; Oorschot DE
Neuroscience; 2003; 118(4):1023-32. PubMed ID: 12732247
[TBL] [Abstract][Full Text] [Related]
20. Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor.
Fischer W; Sirevaag A; Wiegand SJ; Lindsay RM; Björklund A
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8607-11. PubMed ID: 8078930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
